(Q47289672)

English

Very small size proteoliposomes (VSSP) and Montanide combination enhance the humoral immuno response in a GnRH based vaccine directed to prostate cancer

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/22921738

Very small size proteoliposomes (VSSP) and Montanide combination enhance the humoral immuno response in a GnRH based vaccine directed to prostate cancer (English)

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/22921738

author name string

Franklin Fuentes Aguilar

1

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/22921738

Jesús Junco Barranco

2

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/22921738

Eddy Bover Fuentes

3

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/22921738

Lesvia Calzada Aguilera

4

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/22921738

Yovisleydis Lopez Sáez

5

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/22921738

María Dolores Castro Santana

6

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/22921738

Eulogio Pimentel Vázquez

7

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/22921738

Roberto Basulto Baker

8

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/22921738

Osvaldo Reyes Acosta

9

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/22921738

Hilda Garay Pérez

10

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/22921738

Gerardo Guillén Nieto

11

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/22921738

language of work or name

0 references

publication date

23 August 2012

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/22921738

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/22921738

30

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/22921738

46

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/22921738

6595-6599

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/22921738

Anti-GnRH antibodies can induce castrate levels of testosterone in patients with advanced prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.020

7 January 2021

Luteinizing hormone (LH)-releasing hormone: chronic effects on LH and follicle-stimulating hormone cells and secretion in adult male rats

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.020

7 January 2021

Antigenic and immunogenic properties of totally synthetic peptide-based anti-fertility vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.020

7 January 2021

Anti-gonadotrophin releasing hormone antibodies inhibit the growth of MCF7 human breast cancer xenografts

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.020

7 January 2021

A recombinant luteinising-hormone-releasing-hormone immunogen bioeffective in causing prostatic atrophy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.020

7 January 2021

Standard treatments induce antigen-specific immune responses in prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.020

7 January 2021

Heat shock protein 70-associated peptides elicit specific cancer immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.020

7 January 2021

Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.020

7 January 2021

Enhancement of the immune response to poorly immunogenic gangliosides after incorporation into very small size proteoliposomes (VSSP).

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.020

7 January 2021

Montanide ISA 720 and 51: a new generation of water in oil emulsions as adjuvants for human vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.020

7 January 2021

Breakdown of self-tolerance in anergic B lymphocytes.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.020

7 January 2021

OmpA targets dendritic cells, induces their maturation and delivers antigen into the MHC class I presentation pathway

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.08.020

7 January 2021

Identifiers

10.1016/J.VACCINE.2012.08.020

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/22921738

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

13 January 2018

http://europepmc.org/abstract/MED/22921738

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47289672&oldid=2150560534"